Form 424B2 BofA Finance LLC Nov 2, 2026 04:33PM

The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

Filed Pursuant to Rule 424(b)(2)Registration Statement Nos. 333-290665 and 333-290665-01

 

... (continue reading...)


Form SCHEDULE 13G Dermata Therapeutics, Filed by: BIGGER CAPITAL FUND L P Nov 2, 2026 04:33PM html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td { margin: 0; padding: 0; border: 0; outline: 0; font-weight: inherit; font-style: inherit; font-size: 100%; font-family: inherit; vertical-align:... (continue reading...)
Form D/A Psympl Inc. Nov 2, 2026 04:33PM .FormData { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; } .FormDataR { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; text-align: right; } .SmallFormData { color: blue; background-color: white; font-size: 10px; font-family: Times, serif; } .FootnoteData { color:... (continue reading...)
Form POSASR LiveRamp Holdings, Inc. Nov 2, 2026 04:33PM

 

As filed with the Securities and Exchange Commission on November 2, 2026

 

Registration Statement No. 333-262790

Registration Statement No. 333-258563

Registration Statement No. 333-239470

Registration Statement No. 333-215626

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1

TO:

FORM S-3

REGISTRATION STATEMENT NO. 333-262790

FORM S-3

REGISTRATION STATEMENT NO. 333-258563

FORM S-3

... (continue reading...)


Form 424B2 UBS AG Nov 2, 2026 04:33PM

The information in this preliminary pricing supplement is not complete and may be changed. We may not sell these Notes until the pricing supplement, the accompanying product supplement and the accompanying prospectus (collectively, the “Offering Documents”) are delivered in final form. The Offering Documents are not an offer to sell these Notes and we are not soliciting offers to buy these Notes in any state where the offer or sale is not permitted.

 

... (continue reading...)


More SEC Filings

View Older Stories

Nov 2, 2026 04:33PM Form 8-K PROCTER & GAMBLE Co For: Nov 02
Nov 2, 2026 04:33PM Form 8-K RECURSION PHARMACEUTICAL For: Oct 31
Nov 2, 2026 04:33PM Form 8-K TELOS CORP For: Nov 02
Nov 2, 2026 04:33PM Form 144 indie Semiconductor, Filed by: Wu Naixi
Nov 2, 2026 04:33PM Form 424B2 BANK OF MONTREAL /CAN/
Nov 2, 2026 04:33PM Form 424B7 FEDERAL REALTY INVESTMEN
Nov 2, 2026 04:33PM Form 13F-HR Westside Investment Mana For: Sep 30
Nov 2, 2026 04:33PM Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
Nov 2, 2026 04:33PM Form 10-Q CAPITAL SOUTHWEST CORP For: Sep 30
Nov 2, 2026 04:32PM Form 8-K AVITA Medical, Inc. For: Nov 02
Nov 2, 2026 04:32PM Form 144 VISA INC. Filed by: MCINERNEY RYAN
Nov 2, 2026 04:32PM Form 144 Rocket Lab Corp Filed by: Spice Adam C.
Nov 2, 2026 04:32PM Form 497 1290 Funds
Nov 2, 2026 04:32PM Form 424B2 GOLDMAN SACHS GROUP INC
Nov 2, 2026 04:32PM Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
Nov 2, 2026 04:32PM Form 497 UBS FUNDS
Nov 2, 2026 04:32PM Form 424B2 GOLDMAN SACHS GROUP INC
Nov 2, 2026 04:32PM Form 424B2 BofA Finance LLC
Nov 2, 2026 04:32PM Form 10-Q Inspire Medical Systems, For: Sep 30
Nov 2, 2026 04:32PM Form 4 Chewy, Inc. For: Oct 30 Filed by: Singh Sumit
Nov 2, 2026 04:32PM Form 144 Quanex Building Products Filed by: Cornett Paul
Nov 2, 2026 04:32PM Form 424B2 UBS AG
Nov 2, 2026 04:32PM Form 10-Q UPWORK, INC For: Sep 30
Nov 2, 2026 04:32PM Form 8-K UGI CORP /PA/ For: Oct 28
Nov 2, 2026 04:32PM Form 4 ProPetro Holding Corp. For: Oct 30 Filed by: Weatherl Caleb Lyle
Nov 2, 2026 04:32PM Form 424B2 BANK OF MONTREAL /CAN/
Nov 2, 2026 04:32PM Form FWP MORGAN STANLEY Filed by: MORGAN STANLEY
Nov 2, 2026 04:32PM Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
Nov 2, 2026 04:31PM Form 485APOS DEUTSCHE DWS MARKET TRUS
Nov 2, 2026 04:31PM Form 10-Q Axsome Therapeutics, For: Sep 30
Nov 2, 2026 04:31PM Form DEFA14A SYNAPTICS Inc
Nov 2, 2026 04:31PM Form 497J UBS FUNDS
Nov 2, 2026 04:31PM Form 8-K ANAVEX LIFE SCIENCES For: Oct 28
Nov 2, 2026 04:31PM Form 4 SVRN, Inc. For: Sep 22 Filed by: Schwed David L.
Nov 2, 2026 04:31PM Form 144 ACUITY INC. (DE) Filed by: ASHE NEIL
Nov 2, 2026 04:31PM Form 8-K EVgo Inc. For: Nov 02
Nov 2, 2026 04:31PM Form 3 NovaBridge Biosciences For: Nov 02 Filed by: Silberstein Charles
Nov 2, 2026 04:31PM Form 8-K HBT Financial, Inc. For: Oct 29
Nov 2, 2026 04:31PM Form 424B2 BANK OF NOVA SCOTIA
Nov 2, 2026 04:31PM Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
Nov 2, 2026 04:31PM Form 40-17G KKR FS Income Trust
Nov 2, 2026 04:31PM Form 3 Nextpower Inc. For: Nov 01 Filed by: Slusser Sarah A
Nov 2, 2026 04:31PM Form 4 ZIPRECRUITER, INC. For: Oct 29 Filed by: Liaw Jeffrey
Nov 2, 2026 04:31PM Form 10-Q BOISE CASCADE Co For: Sep 30
Nov 2, 2026 04:31PM Form 10-Q ODYSSEY MARINE EXPLORATI For: Sep 30
Nov 2, 2026 04:31PM Form 424B2 JPMORGAN CHASE & CO
Nov 2, 2026 04:31PM Form 8-K LiveRamp Holdings, Inc. For: Nov 02
Nov 2, 2026 04:31PM Form 424B2 CITIGROUP INC
Nov 2, 2026 04:31PM Form 424B2 BARCLAYS BANK PLC
Nov 2, 2026 04:31PM Form 497 1290 Funds
View Older Stories